ADAMTS7 degrades Comp to fuel BMP2-dependent osteogenic differentiation and ameliorate oncogenic potential in osteosarcomas.

FEBS Open Bio
Chao WangLu Zhang

Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, with a high metastatic potential. Despite dramatic changes in OS treatments over the past decades, their efficiency still remains limited, with severe complications and adverse side effects. Key mechanisms underlining tumorigenesis, metastasis and chemotherapy resistance are currently lacking, in turn hindering any progress with respect to developing effective and safe therapeutic strategies against OS. Recently, ADAMTS7, a member of the disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family, was shown to be involved in osteogenic differentiation-related pathological processes. ADAMTS7 promotes vascular calcification via disturbing the balance between osteogenic bone morphogenetic protein (BMP)2 (regulating osteogenic differentiation and bone formation during development) and its natural inhibitor cartilage oligomeric matrix protein (Comp). Hence, in the present study, we aimed to investigate the role of ADAMTS7 in the pathological process of OS. We first revealed that ADAMTS7 was decreased in OS tissues. Lower expression of ADAMTS7 was correlated with poor histological differentiation and an advanced clinical st...Continue Reading

References

Apr 6, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chuan-Ju LiuPaul E Di Cesare
Apr 7, 2006·Journal of Cellular Biochemistry·David Thomas, Maya Kansara
Nov 1, 2006·Clinical Orthopaedics and Related Research·Rex C HaydonTong-Chuan He
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Ritter, S S Bielack
Nov 14, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yu CongXin Shi
Feb 1, 2015·Matrix Biology : Journal of the International Society for Matrix Biology·Santiago Cal, Carlos López-Otín
May 4, 2015·Cellular and Molecular Life Sciences : CMLS·Arantzazu AlfrancaRene Rodriguez
May 31, 2015·Genome Biology·Richard KelwickDylan R Edwards
Oct 3, 2015·Advanced Drug Delivery Reviews·K D HankensonM Shaughnessy
Oct 21, 2016·Rheumatology and Therapy·Ryan A DurfeeHue H Luu
Jul 25, 2017·Trends in Molecular Medicine·Yu-Hsuan LinDung-Fang Lee
Dec 7, 2017·Expert Review of Anticancer Therapy·Douglas J HarrisonRichard Gorlick
Mar 14, 2018·Matrix Biology : Journal of the International Society for Matrix Biology·Karen L PoseyJacqueline T Hecht
Jun 10, 2018·Matrix Biology : Journal of the International Society for Matrix Biology·Timothy J Mead, Suneel S Apte
Nov 23, 2018·OncoTargets and Therapy·Qisheng XiongChia-Ying Lin

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence
surgical resection
PCR
transfections
Assay
transfection
FACS

Software Mentioned

GraphPad
prism
imagej

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

© 2021 Meta ULC. All rights reserved